Author Archives: jakebrooks477@gmail.com

Retatrutide vs Semaglutide

Alluvi Retatrutide

Retatrutide vs Semaglutide The comparison between Retatrutide and Semaglutide highlights the rapid and escalating advancements in pharmacological treatments for obesity and type 2 diabetes. While Semaglutide is a revolutionary, approved drug with an established track record, Retatrutide is a newer, investigational medication. It has shown even greater efficacy in early clinical trials due to its […]

Retatrutide how to get

Alluvi Retatrutide

Retatrutide how to get Retatrutide is an emerging investigational medication generating significant interest due to its impressive performance in early clinical trials for obesity and metabolic conditions. Developed by Eli Lilly, retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors—three pathways involved in appetite regulation, energy expenditure, and metabolic balance. Because of […]